Cargando…
How to make a decision on the choice of therapy for multiple sclerosis with sarcoidosis comorbidity?
Autores principales: | Miletic-Drakulic, Svetlana D., Jankovic, Vladimir S., Radevic, Sandra M., Lazarevic, Snezana R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749581/ https://www.ncbi.nlm.nih.gov/pubmed/36252964 http://dx.doi.org/10.17712/nsj.2022.4.20220024 |
Ejemplares similares
-
VEP Score of a Left Eye Had Predictive Values for Achieving NEDA-3 over Ten Years in Patients with Multiple Sclerosis
por: Miletic-Drakulic, Svetlana, et al.
Publicado: (2022) -
The Agony of Choice? Preserved Affective Decision Making in Early Multiple Sclerosis
por: Landmeyer, Nils C., et al.
Publicado: (2020) -
Trait self-awareness predicts perceptions of choice meaningfulness in a decision-making task
por: Dishon, Noam, et al.
Publicado: (2018) -
Comorbidities of sarcoidosis
por: Tana, Claudio, et al.
Publicado: (2022) -
Making choices—how stochastic decisions determine disease progression
por: Park, Ki-Sun, et al.
Publicado: (2016)